This narrative review examines how cardiopulmonary bypass affects patients undergoing cardiac surgery. The authors looked at various outcomes like inflammation, oxidative stress, and organ dysfunction. Because the study is a review, it does not report new patient data or a specific sample size. Instead, it synthesizes existing information about these complex biological processes.
The evidence remains heterogeneous and inconclusive. Many findings come from preclinical models or rely on indirect measures rather than direct observation of microvascular perfusion in humans. Technical challenges and a lack of standardized endpoints make it difficult to draw firm conclusions about what works best for patients.
Readers should understand that while lab studies suggest certain mechanisms, translating these findings to clinical practice is still difficult. Important gaps remain in moving from experimental models to real-world patient care. Greater integration of bedside imaging and biomarkers may help clarify these issues in the future, but current clinical evidence is not yet definitive.
